About 206,000 results
https://finance.yahoo.com/q?s=abbvView the basic ABBV stock chart on Yahoo Finance. Change the date range,
chart type and compare AbbVie Inc. against other ... AbbVie Inc (ABBV) Files 10-
K for the Fiscal Year Ended on December 31, 2017. AbbVie Inc (NYSE:ABBV)
files its latest 10-K with SEC for the fiscal year ended on December 31, 2017.
https://finance.yahoo.com/quote/ABBV/View the basic ABBV stock chart on Yahoo Finance. Change the ... AbbVie Inc (
NYSE:ABBV) files its latest 10-K with SEC for the fiscal year ended on December
31, 2017. ... AbbVie (ABBV) announces a 35% hike in its quarterly dividend along
with the authorization of a new $10 billion share buyback program by the board.
NYSE, NASDAQ and NYSEMKT data delayed 15 minutes. Real-Time prices
Rating: 4 - 455 votes
provided by BATS BZX. Market data provided by FactSet. Company fundamental
data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key
Statistics provided by Zacks. SEC Filings and Insider Transactions provided by
https://www.marketwatch.com/investing/stock/abbvAbbVie Inc. stock price, stock quotes and financial overviews from MarketWatch.
https://www.thestreet.com/quote/ABBV.htmlView detailed financial information, real-time news, videos, quotes and analysis
on AbbVie Inc. (NYSE:ABBV). Explore commentary on AbbVie Inc. and hear what
the experts at TheStreet are saying about ABBV.
https://seekingalpha.com/article/4145656-abbvie-time-trim-position5 days ago ... AbbVie (ABBV) first appeared in the March to Freedom Fund when the company
split up from Abbott Laboratories (ABT) in 2013. Shortly after the breakup, I sold
my shares of Abbott and doubled my position in AbbVie. This turned out to be a
good move because AbbVie has done very well for our portfolio.
https://seekingalpha.com/.../4141848-abbvie-looks-positioned- outperformanceJan 31, 2018 ... That acknowledged, a quantitative system such as PowerFactors can be a
remarkably effective tool to find promising investing ideas. Speaking of which,
AbbVie (ABBV) is one of the names currently picked by the PowerFactors system,
and the company does in fact look well positioned for attractive returns ...
money.cnn.com/quote/quote.html?symb=ABBVAbbVie Inc (NYSE:ABBV). Add to Watch List. Set Alert ... Latest ABBV News |
Press Releases. AbbVie Inc (ABBV) Files 10-K for the Fiscal Year Ended on
December 31, 2017. Feb 16 / GuruFocus News - Paid Partner Content. Lilly's
Taltz Positive in Phase III Label Expansion Study. Feb 14 / Zacks.com - Paid
AbbVie is a pharmaceutical company that discovers, develops and markets both biopharmaceuticals and small molecule drugs. It originated in 2013 as a spin-off of Abbott Laboratories. Wikipedia
Headquarters: North Chicago
CEO: Richard A. Gonzalez (Jan 2, 2013–)
Revenue: 25.64 billion USD (2016)
Number of employees: 30,000 (2016)
Did you know: AbbVie Inc. is the world's fifth-largest independent biotech company by market cap ($154.4 B).